Simponi golimumab<\/strong> requires an individual specialist plan because the approved dose and monitoring depend on the diagnosis, body weight and treatment response.<\/p>\n TNF-alpha helps coordinate inflammation. In rheumatoid arthritis and related joint diseases, excessive TNF activity contributes to pain, swelling, stiffness and progressive structural damage. In ulcerative colitis, it contributes to inflammation of the colon lining. Golimumab binds soluble and membrane-bound TNF-alpha and prevents it from activating its receptors. This reduces inflammatory signalling, but it can also reduce part of the body’s normal defence against infection.<\/p>\n Depending on the local licence and the patient’s history, Simponi may be prescribed for adults with:<\/p>\n Golimumab also has paediatric indications in certain presentations. However, the Simponi 100 mg pre-filled pen has not been studied in paediatric patients and is not recommended for paediatric use<\/strong>. The prescriber must select the correct product strength and device.<\/p>\n Never calculate or change a Simponi dose without the prescribing specialist. The licensed regimen depends on the diagnosis, body weight, response and product presentation.<\/p>\n The usual adult regimen is 50 mg once a month on the same date<\/strong>. In patients weighing more than 100 kg who do not achieve an adequate response after three or four doses, the specialist may consider increasing the dose to 100 mg once a month<\/strong>. The increased risk of certain serious adverse reactions with 100 mg must be considered, and continued therapy should be reconsidered if the higher dose does not provide benefit after another three or four doses.<\/p>\n Clinical response in ulcerative colitis is usually assessed within 12-14 weeks. Continued treatment should be reconsidered when there is no evidence of therapeutic benefit.<\/p>\n Combining golimumab with other biologic medicines used for the same condition is generally not recommended because infection risk may increase. In particular, combinations with anakinra<\/strong> or abatacept<\/strong> are not recommended. Tell the prescriber about all biologics, immunosuppressants, corticosteroids, anticoagulants, supplements and recent or planned vaccines. Non-live vaccines may be given, but immune response can be reduced; live vaccines and therapeutic infectious agents should not be given concurrently.<\/p>\n Inject the forgotten dose as soon as it is remembered, but do not use a double dose. If the dose is less than two weeks late<\/strong>, inject it and remain on the original schedule. If it is more than two weeks late<\/strong>, inject it and establish a new monthly schedule from that date. Ask the clinic or pharmacist if timing is uncertain.<\/p>\n The most commonly reported adverse effect is an upper respiratory tract infection. Injection-site redness, pain or itching, increased liver enzymes, dizziness and high blood pressure can also occur. Seek urgent medical help for:<\/p>\n Stop-and-seek-advice decisions must be made urgently with the treating team; do not restart after a serious infection unless the specialist confirms it is safe.<\/p>\n No. The usual adult dose is 50 mg monthly. A specialist may consider 100 mg monthly only in patients over 100 kg with an inadequate response after three or four doses.<\/p>\n Non-live vaccines may be used after medical review, although the response may be reduced. Live vaccines must be avoided during golimumab treatment.<\/p>\n No. Let it stand naturally at room temperature for about 30 minutes. Do not use hot water, a microwave or another heat source.<\/p>\n A few small translucent or white protein particles may occur. Do not use the pen if the solution is cloudy, discoloured or contains visible foreign particles; ask the pharmacist or clinic.<\/p>\n No. It is a prescription biologic that requires specialist diagnosis, infection screening, dose selection, injection training and ongoing monitoring. Browse more health information on No Style Like<\/a>, but use the personal plan issued by your treating team.<\/p>\n Medical disclaimer:<\/strong> This product page is educational and does not replace the package leaflet or advice from a qualified physician or pharmacist. Simponi golimumab dosing and monitoring must be individualised by the treating specialist. Never start, stop, switch or change the dose on the basis of online information.<\/p>\n","protected":false},"excerpt":{"rendered":" Simponi golimumab 100 mg\/1 mL<\/strong> is a prescription TNF-inhibitor biologic in a single-use SmartJect pre-filled pen. Review approved uses, diagnosis- and weight-based dosing, TB and hepatitis B screening, infection and vaccine precautions, injection steps and refrigerated storage.<\/p>\n","protected":false},"featured_media":11405310,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[41601],"product_tag":[],"class_list":["post-11403855","product","type-product","status-publish","has-post-thumbnail","product_cat-autoimmune-disease-treatments","first","instock","shipping-taxable","product-type-simple"],"_links":{"self":[{"href":"https:\/\/nostylelike.net\/en\/wp-json\/wp\/v2\/product\/11403855","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nostylelike.net\/en\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/nostylelike.net\/en\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/nostylelike.net\/en\/wp-json\/wp\/v2\/comments?post=11403855"}],"version-history":[{"count":2,"href":"https:\/\/nostylelike.net\/en\/wp-json\/wp\/v2\/product\/11403855\/revisions"}],"predecessor-version":[{"id":11405325,"href":"https:\/\/nostylelike.net\/en\/wp-json\/wp\/v2\/product\/11403855\/revisions\/11405325"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nostylelike.net\/en\/wp-json\/wp\/v2\/media\/11405310"}],"wp:attachment":[{"href":"https:\/\/nostylelike.net\/en\/wp-json\/wp\/v2\/media?parent=11403855"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/nostylelike.net\/en\/wp-json\/wp\/v2\/product_brand?post=11403855"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/nostylelike.net\/en\/wp-json\/wp\/v2\/product_cat?post=11403855"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/nostylelike.net\/en\/wp-json\/wp\/v2\/product_tag?post=11403855"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}![\"Simponi](\"https:\/\/nostylelike.net\/wp-content\/uploads\/2026\/07\/04-simponi-100mg-english-medical-card.jpg\")
Simponi golimumab quick facts<\/h2>\n
\n
How golimumab works<\/h2>\n
Approved uses<\/h2>\n
\n
Diagnosis-based dosing: why 100 mg is not the routine dose for everyone<\/h2>\n
Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and non-radiographic axial spondyloarthritis<\/h3>\n
Ulcerative colitis<\/h3>\n
\n
9 essential safety checks before and during treatment<\/h2>\n
\n
Medicines and vaccines that need review<\/h2>\n
How to use the SmartJect pen safely<\/h2>\n
\n
Missed dose guidance<\/h2>\n
Side effects and when to seek urgent help<\/h2>\n
\n
Storage and travel<\/h2>\n
\n
Frequently asked questions<\/h2>\n
Is Simponi 100 mg the standard monthly dose for rheumatoid arthritis?<\/h3>\n
Can I receive vaccines while using Simponi golimumab?<\/h3>\n
Can the pen be warmed quickly?<\/h3>\n
What if the solution has particles?<\/h3>\n
Can I buy or start Simponi without a specialist?<\/h3>\n
Official medical sources<\/h2>\n
\n